Chris Marschall and Yolande Barnard
(PRESS RELEASE) BRIDGEWATER, NJ — Bausch + Lomb, a global eye health company, announced the appointment of new leadership in its Pharmaceuticals and Consumer Health Care divisions in the U.S.
Yolande Barnard, formerly the vice president, marketing and sales, U.S. Neurology, Bausch Health, will now serve as vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb. Chris Marschall, most recently vice president, marketing for Bausch + Lomb’s U.S. Consumer Health Care business, has been promoted to vice president and general manager, U.S. Consumer Health Care. Barnard and Marschall assume responsibility for the day-to-day management of their respective businesses, ensuring all marketing and sales goals and objectives are met while increasing operating performance.
With more than two decades of experience in the pharmaceutical industry, Barnard has held a number of roles with increasing responsibility in sales, marketing and general management. Since joining Bausch Health (Bausch + Lomb’s parent company) in 2017, she has led the development of marketing strategies and commercial effectiveness initiatives to drive productivity and ensure the growth of products in the U.S. neurology group. She was also responsible for leading the neurology sales organization. Immediately prior to joining Bausch Health, Barnard spent almost 15 years at Novartis in a variety of roles across the marketing and sales functions. Her most recent role at Novartis was in the oncology business as the Global Disease Area Leader where she led the successful global launch of a new treatment for chronic iron overload due to blood transfusions.
Marschall first joined Bausch + Lomb in 2011 as executive director, Global Marketing for the company’s over-the-counter business. During his tenure with the company, he led marketing efforts that helped the Bausch + Lomb Consumer Health Care business reach industry-leading growth for seven consecutive years, as well as a number of other notable achievements. These include the launch of LUMIFY redness reliever eye drops, which became the No. 1 eye doctor recommended redness reliever within one year of launching, more than doubling the household usage of Biotrue multi-purpose solution, which is the No. 1 multi-purpose solution in the United States, and achieving year-over-year, double-digit growth for PreserVision AREDS 2 formula eye vitamins, the No. 1 doctor recommended brand eye vitamin in the nation. Before joining Bausch + Lomb, Marschall held brand management and new product innovation positions at Pfizer Consumer Healthcare and Wyeth Consumer Healthcare, where he led large brands such as Centrum Multivitamins.
Barnard and Marschall will join John Ferris, vice president and general manager, U.S. Vision Care, and Chuck Hess, vice president and general manager, U.S. Surgical, to round out Bausch + Lomb’s fully integrated eye health leadership team in the U.S.
“We are proud to bring this strong and accomplished group of leaders together to support our integrated eye care platform, a significant strength of the business that gives us the ability to offer a varied and deep portfolio to customers and their patients,” said Joe Gordon, U.S. president, Bausch + Lomb. “The expertise, dedication and passion exhibited by these individuals give me great confidence that they will continue to contribute to our company’s growth as we build upon our eye health offerings to advance our mission of helping people see better to live better around the world.”
Barnard and Marschall are based at the company’s headquarters in Bridgewater, NJ.